Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 27 October 2022, 18:04 HKT/SGT
Share:
    

Source: Eminence Business Media
Watch the Biggest T10 Indian Pharma Championship on VOOT live

MUMBAI, INDIA, Oct 27, 2022 - (ACN Newswire) - Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10 Indian Pharma Champions Trophy 2022 scheduled for December 1-7, 2022, in Mumbai. Managing Director of Eminence Business Media, Ms. Guneet Kaur Hayer, believes that cricket is not just a sport for many; it is an emotion and as a company they want people to take a short rejuvenating break from their tiring work, and to do something that works for their physical health, mental health, and fitness at par. She also said it is every company's responsibility to keep their employees healthy, fit, engaged, appreciated and happy with their jobs.


For the first time ever, a cricket league of such a high stature has been announce exclusively for the Pharmaceutical Industry that would make an enduring impact on people's lives. It provides great entertainment, teaches important skills; physical, mental, and social.

What's in It for the Pharma Teams?
1. Winning prize money for up to INR 25 Lakhs.
2. Live streaming gives that celebrity vibe to show your talent on the screen to 20 million viewers.
3. Four-wheeler, two wheelers and several other remunerative awards for Man of the Series, Man of the Matches, Purple Hat, Orange Hat Winners and more.
4. Win gadgets like Laptops, mobiles and more.
5. Best of all is the joy of playing cricket and winning the championship.
6. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

What's in It for the Sponsors?
1. Exclusive Brand Positioning & Visibility.
2. Exclusive marketing
3. Live streaming on VOOT across the nation.
4. On air campaigns in multiple cities.
5. Network and enhance your market reach.
6. Pre- scheduled meetings.
7. Support NGO by participating, or partnering, where in part percentage will go in donation to them.


Topic: Press release summary
Source: Eminence Business Media


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Genius Foundation's GENIUS Token Surges Following TGE, Briefly Tops $800 Million FDV  
Apr 21, 2026 22:46 HKT/SGT
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)  
Tuesday, April 21, 2026 7:52:00 PM
New Report Reveals Widespread Misunderstanding of Consumer Messaging App Security Across Government and Critical Infrastructure  
Apr 21, 2026 19:00 HKT/SGT
Seven HKTDC Lifestyle and Licensing mega events to open next week  
Apr 21, 2026 18:51 HKT/SGT
Hitachi to establish a new company with Nojima under a strategic partnership to accelerate growth of its home appliance business  
Tuesday, April 21, 2026 6:21:00 PM
Global Turbine Asia Advances Aerospace Growth, Capabilities and Talent Development Through Strategic Partnerships  
Apr 21, 2026 17:39 HKT/SGT
GMG's Graphene Engine Oil Additive G(R) LUBRICANT: Patent Granted in USA; Allowed in China  
Apr 21, 2026 17:07 HKT/SGT
Demanlink Unveils Sarawak's First Telecommunications Smart Pole in Siburan and Debuts its First Built-to-Suit Tower in Bintulu  
Apr 21, 2026 16:00 HKT/SGT
Australia's data centre leaders to meet amid surge in AI-driven infrastructure investment  
Apr 21, 2026 12:41 HKT/SGT
BULL and Fujitsu Sign Basic Agreement to Develop Japan's Unique High-Precision Space Situational Awareness Service  
Tuesday, April 21, 2026 10:47:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: